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Risk Factors for Surgical Site Infection Following
Total Joint Arthroplasty
Mohammad R. Rasouli, MD, Camilo Restrepo, MD, Mitchell G. Maltenfort, PhD, James J. Purtill, MD,
and Javad Parvizi, MD, FRCS
Investigation performed at the Rothman Institute of Orthopaedics, Thomas Jefferson University, Philadelphia, Pennsylvania
Background: Currently, most hospitals in the United States are obliged to report infections that occur following total joint
arthroplasty to the Centers for Disease Control and Prevention through the National Healthcare Safety Network surveil-
lance. The objective of this study was to identify the risk factors of surgical site infections that were reported to the Centers
for Disease Control and Prevention from a single institution.
Methods: For this study, 6111 primary and revision total joint arthroplasties performed from April 2010 to June 2012 were
identified. Surgical site infection cases captured by infection surveillance staff on the basis of the Centers for Disease
Control and Prevention definition were identified. Surgical site infection cases with index surgery performed at another
institution were excluded. All cases were followed up for one year for development of surgical site infection. The model for
predictors of surgical site infection was created by logistic regression and was validated by bootstrap resampling.
Results: Of all performed total joint arthroplasties, surgical site infection developed in eighty cases (1.31% [95%
confidence interval, 1.02% to 1.59%]). The highest rate of surgical site infection was observed in revision total knee
arthroplasty (4.57% [95% confidence interval, 2.31% to 6.83%]) followed by revision total hip arthroplasty (1.94% [95%
confidence interval, 0.75% to 3.13%]). Among the variables examined, the predictive factors of surgical site infection were
higher Charlson Comorbidity Index (odds ratio for a Charlson Comorbidity Index of ‡2, 2.29 [95% confidence interval, 1.32
to 3.94] and odds ratio for a Charlson Comorbidity Index of 1, 2.09 [95% confidence interval, 1.06 to 4.10]), male sex
(odds ratio, 1.79 [95% confidence interval, 1.11 to 2.89]), and revision total knee arthroplasty (odds ratio, 3.13 [95%
confidence interval, 1.17 to 8.34]), and a higher level of preoperative hemoglobin (odds ratio, 0.85 per point [95%
confidence interval, 0.73 to 0.98 per point]) was protective against surgical site infection. The C-statistic of the model was
0.709 without correction and 0.678 after bootstrap correction, indicating that the model has fair predictive power.
Conclusions: Low preoperative hemoglobin level is one of the risk factors for surgical site infection and preoperative
correction of hemoglobin may reduce the likelihood of postoperative surgical site infection.
Level of Evidence: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
S
urgical site infection after total joint arthroplasty is a
rare but devastating complication1-3, with these infec-
tions still a major cause of morbidity in surgical pa-
tients4. Treatment of hospital-acquired infections poses a
huge economic burden on health care5,6. As part of the mis-
sion to reduce the burden of hospital-acquired infections, the
Centers for Disease Control and Prevention (CDC) has issued
guidelines for the prevention of surgical site infection that are
currently being updated7. In addition, the CDC requires all
hospitals to report the hospital-acquired infections through
the National Healthcare Safety Network (NHSN) surveillance
program.
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Risk factors for surgical site infection can be categorized
into those relating to the patient’s health status, those that relate
to the surgical environment, and those that arise from clinical
interventions increasing the patient’s inherent risk. It is believed
that identification of patient-related risk factors and their reversal
in some cases can lead to a reduction in surgical site infection8.
Although several studies have been performed to determine risk
factors of surgical site infection following total joint arthro-
plasty1,9-13, risk factors for surgical site infection as defined by the
CDC and required to be reported have not been fully evaluated.
The objective of this case-control study was to determine
the patient-related risk factors for surgical site infection fol-
lowing primary and revision total joint arthroplasty using an
institutional database on joint arthroplasty and the data gen-
erated by the NHSN surveillance.
Materials and Methods
After obtaining approval of the institutional review board, this retrospectivestudy was carried out at our institution and covered the time period from
April 2010 to June 2012. During this time, 2718 total hip arthroplasties, 2549 total
knee arthroplasties, 516 revision total hip arthroplasties, and 328 revision total
knee arthroplasties were performed at our institution. Patients who were iden-
tified by the NHSN surveillance system as developing surgical site infection
during the first year after the total joint arthroplasty were noted. Patients who did
not have their index arthroplasty at our institution were excluded. The institu-
tional database (TheraDoc Infection Control Assistant; TheraDoc, Salt Lake City,
Utah), which includes detailed data related to surgery, microbiology and labo-
ratory results, radiology reports, admission information, data from the phar-
macy, and numerous other data points, was used to extract the pertinent
information needed for this study. Information, including demographic char-
acteristics, Charlson Comorbidity Index
14
, and laboratory and intraoperative
data were obtained using our digital database. At our institution, we use the
Charlson Comorbidity Index to assess underlying comorbidities. The Charlson
Comorbidity Index consists of seventeen items as follows: myocardial infarction,
congestive heart failure, peripheral vascular disease, dementia, cerebrovascular
accident, pulmonary disease, connective tissue disorder, peptic ulcer, mild to
moderate liver disease, and diabetes (each item has a score of 1 point); hemi-
plegia, diabetes with complications, renal disease, and cancer (each item has a
score of 2 points); severe liver disease and metastatic cancer (each item has a score
of 3 points); and acquired immunodeficiency syndrome (AIDS), which scores 6
points
15
. We queried our institutional database using codes from the Interna-
tional Classification of Diseases, Ninth Revision, Clinical Modification (ICD-
9-CM) to identify comorbidity items, which have previously been described
15
.
Because we included age as an independent variable in the multivariate analysis,
we did not adjust the Charlson Comorbidity Index for age.
In this database, all surgical site infection events are defined on the basis
of the CDC/NHSN guideline
7
. At our institution, infection surveillance staff
capture all surgical site infection cases in one of the following four ways: (1) an
alert is sent to the surveillance center from the microbiology laboratory whenever
an organism grows on culture when a culture specimen is taken from a patient;
(2) an alert is issued when, within one year of the index arthroplasty, a patient is
readmitted because of infection to Thomas Jefferson University Hospital; (3) an
automatic check is in place to scan the operating room schedules and to detect the
names of patients who had undergone arthroplasty within the preceding year; or
(4) our institution is informed of patients readmitted to other facilities, as in-
stitutions are required to share this information with each other by The Joint
Commission and Act 52 (the Medical Care Availability and Reduction of Error
[MCARE] Act, which requires certain health-care facilities in Pennsylvania to
report health care-associated infections to the Pennsylvania Department of
Health, the Pennsylvania Health Care Cost Containment Council, and the
Pennsylvania Patient Safety Authority through the CDC’s NHSN). Once the
surveillance center has been informed of patients with possible surgical site
infection, the clinical records of these patients are evaluated to confirm the
diagnosis. Each orthopaedic surgeon receives a quarterly list of the patients with
surgical site infection that is communicated to the CDC.
At our institution, routine infection prevention protocols are in place
for patients undergoing elective arthroplasty that include skin cleansing with
4% chlorhexidine wipes twenty-four hours prior to surgery and administration
of perioperative antibiotics within one hour of surgery and for twenty-four
hours following the surgery.
Statistical Analysis
Because the number of surgical site infection events was relatively small, we only
collected the variables, which were more likely to affect the development of
surgical site infection. Only these variables were included in the logistic regres-
sion analysis to avoid the negative effect of including a large number of variables
in the model when the number of events is small. The models were then sys-
tematically pruned using the Akaike information criterion (AIC)
16
, which
combines model error with model complexity, until the AIC could not be further
optimized. The model included an interaction term between the type of joint
(knee or hip) and the type of surgery (primary or revision) to allow for revision
hip arthroplasties and revision knee arthroplasties having different outcomes.
Multiple imputation was used to compensate for 398 missing preoperative he-
moglobin values out of the 6111 samples. When the model was rerun with only
the complete cases, similar parameter values and significance resulted.
Bootstrap resampling, in which new data sets are randomly generated
using the existing data, was used to validate the model by estimating the potential
bias due to overfitting. The predictive power of the model was estimated by the
C-statistic, also known as the area under the curve (AUC) in receiver operating
characteristic (ROC) plots; an AUC of 1.0 is perfect prediction, and an AUC of 0.5
is equivalent to a coin flip. The C-statistic was adjusted downward on the basis of
the bootstrap results to produce a bias-corrected estimate of the model’s reliability.
Source of Funding
There was no external source of funding for this study.
Results
During the study interval, 6111 total joint arthroplasties wereperformed in 3414 women and 2697 men with a mean
patient age (and standard deviation) of 63.0 ± 11.4 years. Surgical
site infection developed in eighty cases (1.31% [95% confidence
interval (CI), 1.02% to 1.59%]) during the period of study. The
highest rate of surgical site infection was observed following re-
vision total knee arthroplasty at 4.57% (95% CI, 2.31% to 6.83%).
The incidence of infection was 1.94% (95% CI, 0.75% to 3.13%)
after revision total hip arthroplasty, 1.18% (95% CI, 0.77% to
1.58%) after primary total hip arthroplasty, and 0.90% (95% CI,
0.54% to 1.27%) following primary total knee arthroplasty.
Surgical site infection developed in forty-three patients
(1.10% [95% CI, 0.74% to 1.36%]) with a Charlson Comor-
bidity Index of 0, fifteen patients (1.17% [95% CI, 0.58% to
1.76%]) with a Charlson Comorbidity Index of 1, twelve pa-
tients (2.69% [95% CI, 1.1% to 4.19%]) with a Charlson Co-
morbidity Index of 2, and ten patients (3.44% [95% CI, 1.34% to
5.53%]) with a Charlson Comorbidity Index of ‡3. Surgical
site infection was observed in thirty-six women (1.05% [95% CI,
0.71% to 1.40%]) and forty-four men (1.63% [95% CI, 1.15%
to 2.11%]). The highest rate of surgical site infection at 4.23%
(95% CI, 0.92% to 7.53%) was in patients with a preoperative
hemoglobin level of £10 g/dL. Patients with a preoperative he-
moglobin level of 12 to 13 g/dL had the lowest rate of surgical site
infection at 0.84% (95% CI, 0.35% to 1.34%).
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Multivariate logistic regression was used to examine po-
tential predictors of surgical site infection, including age, sex,
body mass index, unadjusted Charlson Comorbidity Index,
month of surgery, type of surgery, and preoperative measure-
ments of serum albumin, serum glucose, and hemoglobin.
Among these, the predictive factors were higher Charlson Co-
morbidity Index (the odds ratios for the Charlson Comorbidity
Index of ‡2 were 2.29 [95% CI, 1.32 to 3.94] compared with the
Charlson Comorbidity Index of 0 and 2.09 [95% CI, 1.06 to
4.10] compared with the Charlson Comorbidity Index of 1),
male sex (odds ratio, 1.79 [95% CI, 1.11 to 2.89]), and revision
total knee arthroplasty (odds ratio, 3.13 [95% CI, 1.17 to 8.34]),
and a higher preoperative hemoglobin level (odds ratio, 0.85 per
point [95% CI, 0.73 to 0.98 per point]) was protective against the
surgical site infection (Table I). The C-statistic or AUC of the
model was 0.709 without correction and 0.678 after bootstrap
correction for model optimism (200 bootstrap samples). These
similar values indicate that there was very little bias because of
overfitting and that the model has fair predictive power.
Discussion
Hospital-acquired infections place an immense economicburden on health-care costs1-3,5,6. The CDC and other
regulatory bodies have provided mandates and guidelines that
are intended to reduce the burden of hospital-acquired infec-
tions. Part of the CDC mandate is the reporting of hospital-
acquired infections through the NHSN surveillance system.
Although several studies have been carried out to determine risk
factors of surgical site infection in patients undergoing total joint
arthroplasty1,9-13, the risk factors for developing surgical site in-
fection, as defined by the CDC and NHSN criteria, have not been
well established. The present study was conducted to identify all
of the risk factors for surgical site infection following total joint
arthroplasty in a single, high-volume arthroplasty center.
In the present study, using comprehensive arthroplasty as
well as the surgical site infection database, the potential role of
numerous risk factors for surgical site infection was evaluated.
One of the strengths of this study was that detailed data on all
patients who had undergone arthroplasty were collected in a
prospective manner. Thus, as there were few missing data on the
entire cohort, the intended analyses were allowed. Our infection
surveillance center constantly updates the surgical site infection
database and reports its findings to the CDC as mandated by the
Commonwealth of Pennsylvania (Act 52). Thus, we are confi-
dent that the data set in this relatively large cohort enabled us to
perform a meaningful analysis to identify the risk factors for
surgical site infection. The detailed data collected from the pa-
tients with surgical site infection were compared with the entire
cohort, and appropriate statistical analyses, including multivar-
iate analyses, were performed. To avoid a negative effect of a
small number of surgical site infections on the logistic regression
analysis, only variables with the highest probability of effect on
surgical site infection were entered into the model.
This study identified a number of risk factors for surgical
site infection. Consistent with previous studies1,13,17,18, this study
also identified underlying comorbidities as a risk factor for
surgical site infection following total joint arthroplasty. We
utilized the Charlson Comorbidity Index to overcome the
TABLE I Results of Multivariate Analysis for Identifying Independent Variables of Surgical Site Infection
Variable Odds Ratio* P Value
Sex 0.01
Female 1 (Reference)
Male 1.79 (1.11 to 2.89)
Charlson Comorbidity Index 0.01
0 1 (Reference)
‡2 2.29 (1.32 to 3.94)
Preoperative hemoglobin level 0.03
£10 g/dL 1 (Reference)
12 to 13 g/dL 0.85 (0.73 to 0.98)
Type of surgery 0.48
Primary total joint arthroplasty 1 (Reference)
Revision total joint arthroplasty 1.30 (0.62 to 2.75)
Type of primary total joint arthroplasty 0.29
Total hip arthroplasty 1 (Reference)
Total knee arthroplasty 0.75 (0.44 to 1.29)
Interaction between joint and surgery 0.02
Primary surgery and hip joint 1 (Reference)
Revision surgery and knee joint 3.13 (1.17 to 8.34)
*The values are given as the odds ratios, with the 95% CI in parentheses.
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limitation of other comorbidity scales such as the subjectivity of
the American Society of Anesthesiologists (ASA) score. The
undisputed association between medical comorbidities and the
potential risk for surgical site infection highlights the need for
optimization of these patients prior to surgery that may translate
to a reduction in surgical site infection. One of the most im-
portant modifiable factors strongly associated with surgical site
infection is preoperative anemia. This finding was in agreement
with a prior study from our institution on 15,722 patients that
also found anemia to be a predisposing factor for periprosthetic
joint infection19. There are many reasons that may account for
the higher incidence of surgical site infection in patients with
anemia. The higher incidence of blood transfusion, with all its
adverse effects such as immunomodulation, may be one of the
main reasons for the association between preoperative anemia
and subsequent surgical site infection18,20. However, it should be
pointed out that a hemoglobin level of £10 g/dL is very low and
may indicate an underlying disease such as renal failure, in-
flammatory arthropathies, and malnutrition causing anemia,
and it might not be possible to simply correct the hemoglobin
level without addressing the underlying disorder. In the present
study, we entered ASA score and Charlson Comorbidity Index in
the multivariate model to adjust our findings for the possible
effect of comorbidities on the surgical site infection. However,
the preoperative hemoglobin level was still associated with a
higher risk of surgical site infection, and its effect seems to be
independent of patients’ comorbidities.
In the present study, revision surgery in general and re-
vision total knee arthroplasty in particular were associated with
a greater risk of surgical site infection. The latter is in agree-
ment with other studies and may be explained by the com-
plexity of these cases, longer operative time, larger blood loss,
and unrecognized and occult infections that led to the failure of
these cases in the first instance17,21.
This study, again in agreement with a previously pub-
lished report17, found male sex to be a risk factor for surgical
site infection. However, female sex was not a risk factor for
surgical site infection. This phenomenon may be explained by
the effect of sex hormones on the immune system in that
estrogen enhances the immune function22 while testosterone
suppresses the immune function22,23. Moreover, variations in
societal roles and differences in exposure to infecting organ-
isms between men and women may also have an effect22.
This study had many strengths, including completeness
of the database, a large consecutive cohort of primary and
revision arthroplasty that allowed us to conduct a multivariate
analysis, and the uniformity in our care protocols that mini-
mized the confounding effect of issues such as perioperative
antibiotics. Finally, this study utilized the CDC/NHSN defini-
tion of surgical site infection, which removes the variability that
may exist in defining infection.
The study also had some limitations. Despite the avail-
ability of a comprehensive database, this retrospective study has
the shortcomings of a study design such as nonuniformity of
data collection and bias. Despite all efforts to capture every
surgical site infection that occurred following total joint ar-
throplasty in this cohort, it is possible that some cases of surgical
site infection seen and treated on an outpatient basis may have
been missed. We believe that the latter is unlikely, as ordering of
culture from any specimens would have led to the notification of
the infection surveillance center. We included only variables with
the highest probability of affecting surgical site infection in the
model to avoid the potential negative effect that entering too
many variables in the presence of a small number of events could
have on the model. This might be considered as one of the
limitations of this study; however, we used various statistical tests
to make sure that the model output is accurate.
In conclusion, this study comprising a relatively large
cohort of patients undergoing total joint arthroplasty at a single
institution has identified various risk factors of surgical site in-
fection. We recognized that a low hemoglobin level may be as-
sociated with other comorbidities and various states of chronic
disease. As such, correcting a low hemoglobin level, in isolation,
may not mitigate its apparent effect on the incidence of surgical
site infection. To make a definitive statement, a study would be
required evaluating the impact of preoperative optimization of
hemoglobin in which one group had optimized preoperative
hemoglobin and one group had preoperative hemoglobin that
was not optimized. However, such a study may not be possible
under current guidelines for human experimentation. As rig-
orous statistical analysis suggests that a low hemoglobin level is
an independent risk factor, it is our current recommendation
that a preoperative hemoglobin level of <10 mg/dL be corrected
directly or any identifiable underlying chronic disease be ad-
dressed, prior to total joint arthroplasty. n
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